This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated NOD1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NOD1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~107.7 kDa | |
| Observed band | ~107 kDa | |
| Gel | 8–10% | |
| Negative control | siRNA / KO lysate |
| PTM | Ubiquitinated | |
| Caveat | Multiple splice isoforms | |
| Regulation | IFNγ up | |
| Isoform | 3 isoform(s) |
Literature-validated Western blot parameters for NOD1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human THP-1 , Lane 2: human U20S , Lane 3: human HELA . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-CARD4/NOD1 antigen affinity purified polyclonal antibody (Catalog # A00495-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for CARD4/NOD1 at approximately 107KD. The expected band size for CARD4/NOD1 is at 107KD |
| Gel % | 8–10% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 107 kDa |
NOD1's 107.7 kDa predicted mass matches its ~107 kDa observed band, since it lacks glycosylation, cleavage, or disulfide dimerization that would shift migration.
| single sharp band near ~107 kDa | matches NOD1's predicted 107.7 kDa mass since there is no signal peptide, propeptide, or glycosylation to shift its apparent size |
| several bands at differing molecular weights | reflects expression of the three annotated NOD1 splice isoforms rather than degradation |
| band strongly present in whole-cell lysate | consistent with NOD1's cytoplasmic and membrane-associated localization rather than secretion |
| faint ladder or smear above the main band, especially after ligand stimulation | reflects ubiquitin-like conjugation of NOD1 during innate immune signaling activation |
| high-molecular-weight complex only under native or non-reducing lysis | reflects ligand-induced, non-covalent CARD-CARD homooligomerization that dissociates under standard denaturing SDS-PAGE |
| smaller fragment bands below the main band | may reflect caspase-mediated cleavage of NOD1 during apoptotic signaling |
| predicted mass from UniProt | 107.7 kDa full-length protein with no signal peptide or propeptide cleavage, closely matching the ~107 kDa observed band |
| absence of glycosylation sites | no glyco-associated upward smear, so the band runs close to the predicted mass |
| named splice isoforms (1, 2, 3) | different isoforms can produce additional bands of relatively smaller or larger apparent size than the canonical form |
| lipid anchor / palmitoylation (membrane lipoprotein) | covalent lipid modification anchors NOD1 to the membrane and can alter extraction efficiency and mobility slightly |
| ubiquitin-like (Ubl) conjugation | ligand-activated NOD1 can acquire ubiquitin-like modifications, producing a higher-molecular-weight ladder or smear above the main band |
| non-covalent homooligomerization (no inter-chain disulfide present) | ligand-induced CARD-CARD oligomer complexes typically dissociate to the monomer band under standard reducing SDS-PAGE |
| Situation | Likely cause | Next action |
|---|---|---|
| Multiple bands | the three annotated NOD1 splice isoforms are co-expressed | compare band pattern to isoform-specific transcript data and confirm which isoform the antibody epitope targets |
| Band higher than expected | incompletely dissociated ligand-induced homooligomer complexes or ubiquitin-like conjugation adding mass | ensure complete denaturation with SDS and reducing agent, and compare unstimulated versus ligand-stimulated lysates |
| Weak or no signal | NOD1 is a low-abundance cytoplasmic and membrane-associated innate immune sensor | increase total protein loading or enrich by immunoprecipitation before blotting |
| Fragments below expected size | caspase-mediated cleavage of NOD1 during apoptotic signaling | include protease and caspase inhibitors in lysis buffer and keep samples cold throughout preparation |
| Broad smear instead of sharp band | heterogeneous ubiquitin-like conjugation of NOD1 following pathway activation | compare resting versus stimulated lysates and consider a deubiquitinase treatment control |
| No band in lysate | the palmitoylated, membrane lipid-anchored pool of NOD1 is not solubilized by a mild lysis buffer | use a detergent-based lysis buffer to extract the membrane-associated fraction |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for NOD1, answered from its protein features.
BosterBio's NOD1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Boster's anti-NOD1/CARD4 antibodies are top-performing, extensively cited reagents validated across multiple platforms, with orthogonal confirmation against negative-control tissues and complementary detection methods, giving researchers confident, reproducible Western blot results for NOD1 detection.
Which to pick: Both A00495-2 and PB9294 target CARD4/NOD1 and include real Western blot validation images; choose either for reliable detection, selecting based on your preferred vendor documentation or lot availability since both offer comparable validated WB performance.